메뉴 건너뛰기




Volumn 101, Issue 2, 2010, Pages 115-119

Helicobacter pylori infection and diabetes

Author keywords

Bacteria; Diabetes mellitus; Gastrointestinal diseases; Helicobacter pylori

Indexed keywords

ANTIBIOTIC AGENT;

EID: 77954692353     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (32)

References (50)
  • 1
    • 46449108600 scopus 로고    scopus 로고
    • Gastritis, dyspepsia and peptic ulcer disease
    • Dore MP, Graham DY. Gastritis, dyspepsia and peptic ulcer disease. Minerva Med 2008;99:323-33.
    • (2008) Minerva Med , vol.99 , pp. 323-333
    • Dore, M.P.1    Graham, D.Y.2
  • 2
    • 52649148004 scopus 로고    scopus 로고
    • Potential relationship between Helicobacter pylori and ischemic heart disease:any pathogenic model?
    • Berrutti M, Pellicano R, Fagoonee S, Astegiano M, Smedile A, Saracco G et al. Potential relationship between Helicobacter pylori and ischemic heart disease:any pathogenic model? Panminerva Med 2008;50:161-3.
    • (2008) Panminerva Med , vol.50 , pp. 161-163
    • Berrutti, M.1    Pellicano, R.2    Fagoonee, S.3    Astegiano, M.4    Smedile, A.5    Saracco, G.6
  • 6
    • 0034902268 scopus 로고    scopus 로고
    • Ruolo dell'infezione da Helicobacter pylori nel diabete mellito insulino-dipendente
    • Ojetti V, Pitocco D, Ghirlanda G, Gasbarrini G, Gasbarrini A. Role of Helicobacter pylori infection in insulin-dependent diabetes mellitus. Minerva Med 2001;92:137-44. (Pubitemid 32708888)
    • (2001) Minerva Medica , vol.92 , Issue.3 , pp. 137-144
    • Ojetti, V.1    Pitocco, D.2    Ghirlanda, G.3    Gasbarrini, G.4    Gasbarrini, A.5
  • 9
    • 0034967953 scopus 로고    scopus 로고
    • Prevalence and comparisons of five different diagnostic methods for Helicobacter pylori in diabetic patients
    • DOI 10.1081/ERC-100107179
    • Senturk O, Canturk Z, Cetinarslan B, Ercin C, Hulagu S, Canturk NZ. Prevalence and comparisons of five different diagnostic methods for Helicobacter pylori in diabetic patients. Endocr Res 2001;27:179-89. (Pubitemid 32565587)
    • (2001) Endocrine Research , vol.27 , Issue.1-2 , pp. 179-189
    • Senturk, O.1    Canturk, Z.2    Cetinarslan, B.3    Ercin, C.4    Hulagu, S.5    Canturk, N.Z.6
  • 11
    • 21444455419 scopus 로고    scopus 로고
    • Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy
    • Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M et al. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest 2005;28:214-7.
    • (2005) J Endocrinol Invest , vol.28 , pp. 214-217
    • Gulcelik, N.E.1    Kaya, E.2    Demirbas, B.3    Culha, C.4    Koc, G.5    Ozkaya, M.6
  • 12
    • 0024973424 scopus 로고
    • The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice
    • Simon L, Tornoczky J, Toth M, Jambor M, Sudar Z. The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice. Orvosi Hetilap 1989;130:1325-9.
    • (1989) Orvosi Hetilap , vol.130 , pp. 1325-1329
    • Simon, L.1    Tornoczky, J.2    Toth, M.3    Jambor, M.4    Sudar, Z.5
  • 13
    • 0030118803 scopus 로고    scopus 로고
    • Gastric infection by helicobacter pylori and antral gastritis in Hyperglycemic obese and in diabetic subjects
    • Perdichizzi G, Bottari M, Pallio S, Fera MT, Carbone M, Barresi G. Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. New Microbiol 1996;19:149-54. (Pubitemid 126467358)
    • (1996) New Microbiologica , vol.19 , Issue.2 , pp. 149-154
    • Perdichizzi, G.1    Bottari, M.2    Pallio, S.3    Fera, M.T.4    Carbone, M.5    Barresi, G.6
  • 14
    • 0032193026 scopus 로고    scopus 로고
    • The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with Type 2 diabetes mellitus
    • DOI 10.1016/S0168-8227(98)00088-6, PII S0168822798000886
    • Gentile S, Turco S, Oliviero B, Torella R. The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 1998;42:41-8. (Pubitemid 29003034)
    • (1998) Diabetes Research and Clinical Practice , vol.42 , Issue.1 , pp. 41-48
    • Gentile, S.1    Turco, S.2    Oliviero, B.3    Torella, R.4
  • 15
    • 0029940383 scopus 로고    scopus 로고
    • Non-ulcer dyspepsia and Helicobacter pylori in type 2 diabetic patients: Association with autonomic neuropathy
    • DOI 10.1016/0168-8227(96)01207-7
    • Persico M, Suozzo R, De Seta M, Montella F, Torella R, Gentile S. Non-ulcer dyspepsia and Helicobacter pylori in type 2 diabetic patients: association with autonomic neuropathy. Diabetes Res Clin Pract 1996;31:87-92. (Pubitemid 26179916)
    • (1996) Diabetes Research and Clinical Practice , vol.31 , Issue.1-3 , pp. 87-92
    • Persico, M.1    Suozzo, R.2    De Seta, M.3    Montella, F.4    Torella, R.5    Gentile, S.6
  • 19
    • 0034967952 scopus 로고    scopus 로고
    • Helicobacter pylori infection in Chinese subjects with type 2 diabetes
    • Ko GT, Chan FK, Chan WB, Sung JJ, Tsoi CL, To KF et al. Helicobacter pylori infection in Chinese subjects with type 2 diabetes. Endocr Res 2001;27:171-7.
    • (2001) Endocr Res , vol.27 , pp. 171-177
    • Ko, G.T.1    Chan, F.K.2    Chan, W.B.3    Sung, J.J.4    Tsoi, C.L.5    To, K.F.6
  • 23
    • 68249160053 scopus 로고    scopus 로고
    • Helicobacter pylori infection as a risk factor for insulin resistance
    • Eshraghian A, Hashemi SA, Jahromi AH. Helicobacter pylori infection as a risk factor for insulin resistance. Dig Dis Sci 2009;54:1966-70.
    • (2009) Dig Dis Sci , vol.54 , pp. 1966-1970
    • Eshraghian, A.1    Hashemi, S.A.2    Jahromi, A.H.3
  • 24
    • 46449121984 scopus 로고    scopus 로고
    • Insulin resistance and the metabolic syndrome
    • Lann D, Gallagher E, Leroith D. Insulin resistance and the metabolic syndrome. Minerva Med 2008;99:253-62.
    • (2008) Minerva Med , vol.99 , pp. 253-262
    • Lann, D.1    Gallagher, E.2    Leroith, D.3
  • 27
    • 0035347213 scopus 로고    scopus 로고
    • Prevalence of Gastrointestinal Symptoms in Children and Adolescents with Type 1 Diabetes
    • Vazeou A, Papadopoulou A, Booth IW, Bartsocas CS. Prevalence of gastrointestinal symptoms in children and adolescent with type 1 diabetes. Diabetes Care 2001;24:962-4. (Pubitemid 33636082)
    • (2001) Diabetes Care , vol.24 , Issue.5 , pp. 962-964
    • Vazeou, A.1    Papadopoulou, A.2    Booth, I.W.3    Bartsocas, C.S.4
  • 28
    • 0027618810 scopus 로고
    • Helicobacter pylori in patients with diabetes mellitus
    • Kojecky V, Roubalik J, Bartonikova N. Helicobacter pylori in patients with diabetes mellitus. Vnitr Lek 1993;39:581-4.
    • (1993) Vnitr Lek , vol.39 , pp. 581-584
    • Kojecky, V.1    Roubalik, J.2    Bartonikova, N.3
  • 31
    • 0026659631 scopus 로고
    • Acid peptic disease in children with type I diabetes mellitus: A complicating relationship
    • Burghen GA, Murrell LR, Whitington GL, Klyce MK, Burstein S. Acid peptic disease in children with type I diabetes mellitus: a complicating relationship. Am J Dis Child 1992;146:718-22.
    • (1992) Am J Dis Child , vol.146 , pp. 718-722
    • Burghen, G.A.1    Murrell, L.R.2    Whitington, G.L.3    Klyce, M.K.4    Burstein, S.5
  • 35
    • 7144261722 scopus 로고    scopus 로고
    • One week triple therapy for H.pylori eradication: Ranitidine bismuth citrate plus medium dose clarithromycin and either tinidazole or amoxicillin
    • Cammarota G, Cannizzaro O, Tursi A, Papa A, Gasbarrini A, Cuoco L et al. One week triple therapy for H.pylori eradication: ranitidine bismuth citrate plus medium dose clarithromycin and either tinidazole or amoxicillin. Aliment Pharmacol Ther 1998;12:539-43.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 539-543
    • Cammarota, G.1    Cannizzaro, O.2    Tursi, A.3    Papa, A.4    Gasbarrini, A.5    Cuoco, L.6
  • 39
    • 16544374523 scopus 로고    scopus 로고
    • Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes
    • Candelli M, Rigante D, Marietti G, Nista E, Crea F, Schivino A et al. Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes. J Ped Gastroenterol Nutr 2004;38:422-5.
    • (2004) J Ped Gastroenterol Nutr , vol.38 , pp. 422-425
    • Candelli, M.1    Rigante, D.2    Marietti, G.3    Nista, E.4    Crea, F.5    Schivino, A.6
  • 43
    • 0025793540 scopus 로고
    • The effects of diabetes mellitus on pharmocokinetics and pharmacodynamics in humans
    • Gwilt PR, Nahas RR, Tracewell WG. The effects of diabetes mellitus on pharmocokinetics and pharmacodynamics in humans. Clin Pharmacokinet 1991;20:477-90.
    • (1991) Clin Pharmacokinet , vol.20 , pp. 477-490
    • Gwilt, P.R.1    Nahas, R.R.2    Tracewell, W.G.3
  • 44
    • 0026987989 scopus 로고
    • Infections in the diabetic patient: The role of immune dysfunction and pathogen virulance factors
    • Bessman AN, Sapico FL. Infections in the diabetic patient: the role of immune dysfunction and pathogen virulance factors. J Diabetic Complications 1992;6:258-62.
    • (1992) J Diabetic Complications , vol.6 , pp. 258-262
    • Bessman, A.N.1    Sapico, F.L.2
  • 45
    • 73849132932 scopus 로고    scopus 로고
    • Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients
    • Demir M, Gokturk HS, Ozturk NA, Arslan H, Serin E, Yilmaz U. Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients. South Med J 2009;102:1116-20.
    • (2009) South Med J , vol.102 , pp. 1116-1120
    • Demir, M.1    Gokturk, H.S.2    Ozturk, N.A.3    Arslan, H.4    Serin, E.5    Yilmaz, U.6
  • 46
    • 0022614124 scopus 로고
    • Pathogenesis of diabetic microangiopathy. The hemodynamic view
    • DOI 10.1016/0002-9343(86)90719-9
    • Zatz R, Brenner BM. Pathogenesis of diabetic microangiopaty: the eaemodynamic view. Am J Med 1986;80:443-53. (Pubitemid 16098781)
    • (1986) American Journal of Medicine , vol.80 , Issue.3 , pp. 443-453
    • Zatz, R.1    Brenner, B.M.2
  • 47
    • 0031893267 scopus 로고    scopus 로고
    • A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China)
    • DOI 10.1016/S0016-5085(98)70475-5
    • Mitchell HM, Hu P, Chi Y, Chen MH, Li YY, Hazell SL. A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation [China]. Gastroenterology 1998;114:256-61. (Pubitemid 28093531)
    • (1998) Gastroenterology , vol.114 , Issue.2 , pp. 256-261
    • Mitchell, H.M.1    Hu, P.2    Chi, Y.3    Min Hu, C.4    Yu Yuan, L.5    Hazell, S.L.6
  • 49


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.